MAGNESIUM CHLORIDE

MAGNESIUM CHLORIDE was reported 31086 times

MAGNESIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACTOBACILLUS TEST POSITIVE 4 0.1905
1 TONSILLAR HAEMORRHAGE 10 0.0685
2 PERICORONITIS 5 0.0549
3 ACTIVITIES OF DAILY LIVING ASSESSMENT 1 0.0500
4 HYPOCHOLESTEROLAEMIA 16 0.0453
5 ADMINISTRATION SITE CELLULITIS 1 0.0286
6 VAGINAL FLATULENCE 8 0.0264
7 LUPUS VULGARIS 30 0.0238
8 LACTOBACILLUS INFECTION 3 0.0183
9 GRIP STRENGTH 4 0.0175
10 RETINITIS 26 0.0150
11 DISLOCATION OF VERTEBRA 28 0.0123
12 MICROCYTOSIS 3 0.0121
13 PERIPHERAL VENOUS DISEASE 47 0.0115
14 SPIDER NAEVUS 2 0.0108
15 INFERIOR VENA CAVA DILATATION 2 0.0095
16 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
17 FACET JOINT SYNDROME 29 0.0089
18 ONYCHOMADESIS 34 0.0081
19 MEAN ARTERIAL PRESSURE DECREASED 2 0.0079
20 BLEPHAROSPASM 49 0.0078
21 HYPERMAGNESAEMIA 5 0.0077
22 DELIVERY 5 0.0076
23 INFUSION SITE REACTION 22 0.0074
24 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 4 0.0071
25 BREAST CANCER STAGE III 46 0.0071
26 RHEUMATIC FEVER 31 0.0069
27 MUSCLE INJURY 56 0.0068
28 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 48 0.0067
29 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 8 0.0064
30 ONYCHOMYCOSIS 25 0.0057
31 REGURGITATION 19 0.0055
32 VASOPLEGIA SYNDROME 9 0.0055
33 ADMINISTRATION SITE DISCOMFORT 1 0.0053
34 HYPERCHOLESTEROLAEMIA 50 0.0052
35 FOLLICULITIS 51 0.0049
36 NAIL DISORDER 42 0.0048
37 VITAMIN B12 DEFICIENCY 19 0.0047
38 FEMALE GENITAL TRACT FISTULA 8 0.0047
39 DEEP VEIN THROMBOSIS POSTOPERATIVE 9 0.0045
40 BACK INJURY 48 0.0044
41 SWOLLEN JOINT COUNT INCREASED 14 0.0044
42 IMMUNOGLOBULINS DECREASED 6 0.0044
43 BURSITIS 53 0.0044
44 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
45 LIP DRY 39 0.0043
46 HELICOBACTER INFECTION 44 0.0043
47 JOINT RANGE OF MOTION DECREASED 57 0.0042
48 PEMPHIGUS 52 0.0042
49 DUODENAL ULCER PERFORATION 30 0.0040
50 BONE EROSION 14 0.0040
51 X-RAY ABNORMAL 7 0.0039
52 C-REACTIVE PROTEIN ABNORMAL 25 0.0039
53 SYNOVITIS 66 0.0037
54 BLOOD MAGNESIUM ABNORMAL 2 0.0036
55 LIVE BIRTH 30 0.0036
56 HAND DEFORMITY 47 0.0036
57 PERICARDITIS 60 0.0036
58 EXOSTOSIS 32 0.0035
59 RIGHT VENTRICULAR DILATATION 2 0.0035
60 SENSE OF OPPRESSION 4 0.0034
61 C-REACTIVE PROTEIN 3 0.0032
62 GLOSSODYNIA 72 0.0032
63 IRRITABLE BOWEL SYNDROME 67 0.0031
64 COMPARTMENT SYNDROME 8 0.0031
65 TASTE DISORDER 62 0.0031
66 RADICULOPATHY 8 0.0030
67 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 2 0.0030
68 PLASMA CELL MYELOMA REFRACTORY 4 0.0030
69 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33 0.0030
70 PLEURAL THICKENING 2 0.0029
71 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0029
72 OVERLAP SYNDROME 2 0.0029
73 PROCTITIS 8 0.0029
74 PORPHYRIA ACUTE 4 0.0028
75 COMA SCALE ABNORMAL 8 0.0028
76 BRAIN CONTUSION 2 0.0027
77 GRIP STRENGTH DECREASED 24 0.0027
78 FINGER DEFORMITY 13 0.0027
79 ABSCESS RUPTURE 1 0.0027
80 TENDON DISCOMFORT 2 0.0026
81 RHEUMATOID FACTOR POSITIVE 15 0.0026
82 EPIDIDYMITIS 3 0.0026
83 OBESITY 41 0.0026
84 WOUND INFECTION 28 0.0026
85 BREAST CALCIFICATIONS 2 0.0025
86 THYROID HORMONES DECREASED 2 0.0025
87 CHRONIC RESPIRATORY FAILURE 3 0.0025
88 BLOOD MAGNESIUM DECREASED 21 0.0024
89 MATERNAL EXPOSURE TIMING UNSPECIFIED 9 0.0024
90 ULCER HAEMORRHAGE 16 0.0024
91 ORAL INFECTION 9 0.0023
92 ANAEMIA OF CHRONIC DISEASE 2 0.0022
93 PROTEIN URINE 2 0.0022
94 BREAST CANCER STAGE II 18 0.0022
95 LIVER INJURY 53 0.0022
96 CHRONIC SINUSITIS 8 0.0021
97 WOUND 59 0.0021
98 IMPAIRED HEALING 68 0.0021
99 PRODUCT LABEL CONFUSION 12 0.0021
100 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 13 0.0020
101 HYPERPARATHYROIDISM SECONDARY 5 0.0020
102 OROPHARYNGEAL DISCOMFORT 18 0.0020
103 STOMA COMPLICATION 2 0.0020
104 ACCIDENT AT HOME 1 0.0019
105 PRODUCT COMMINGLING 2 0.0019
106 ORCHITIS 2 0.0019
107 MIGRAINE WITH AURA 5 0.0018
108 CONGENITAL ANOMALY 14 0.0018
109 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
110 MYOCARDIAL INJURY 2 0.0018
111 NIGHT SWEATS 57 0.0018
112 SERONEGATIVE ARTHRITIS 2 0.0017
113 NEPHROGENIC ANAEMIA 8 0.0017
114 PSEUDOMONAL SEPSIS 3 0.0017
115 ADENOMYOSIS 1 0.0017
116 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
117 PULSE ABSENT 8 0.0017
118 PHARYNGEAL INFLAMMATION 2 0.0016
119 INFUSION SITE WARMTH 2 0.0016
120 CONTRAINDICATED PRODUCT ADMINISTERED 49 0.0016
121 JOINT WARMTH 2 0.0016
122 C-REACTIVE PROTEIN INCREASED 58 0.0016
123 ADENOCARCINOMA PANCREAS 2 0.0016
124 TYPE 2 DIABETES MELLITUS 52 0.0015
125 PSORIATIC ARTHROPATHY 62 0.0015
126 OESOPHAGEAL HAEMORRHAGE 2 0.0015
127 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
128 BODY MASS INDEX INCREASED 2 0.0015
129 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
130 NORMAL NEWBORN 8 0.0015
131 CARBOHYDRATE ANTIGEN 125 INCREASED 5 0.0015
132 DRUG TOLERANCE DECREASED 4 0.0014
133 PERIPHERAL ARTERY OCCLUSION 2 0.0014
134 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
135 NEUROENDOCRINE TUMOUR 2 0.0014
136 SYSTEMIC LUPUS ERYTHEMATOSUS 50 0.0014
137 FREQUENT BOWEL MOVEMENTS 38 0.0014
138 FIBROMYALGIA 34 0.0014
139 FAECES SOFT 10 0.0014
140 INFUSION RELATED REACTION 90 0.0014
141 TONSILLITIS 7 0.0013
142 LUNG DISORDER 65 0.0013
143 OSTEOARTHRITIS 56 0.0013
144 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
145 PNEUMONIA PSEUDOMONAL 2 0.0013
146 RENAL FUNCTION TEST ABNORMAL 6 0.0013
147 JOINT DESTRUCTION 2 0.0013
148 AUTOIMMUNE DISORDER 12 0.0012
149 COSTOCHONDRITIS 2 0.0012
150 BACTERIAL SEPSIS 4 0.0012
151 MUSCULOSKELETAL PAIN 64 0.0012
152 EPILEPSY 37 0.0012
153 PUSTULAR PSORIASIS 4 0.0012
154 ABDOMINAL LYMPHADENOPATHY 1 0.0012
155 HYPOMAGNESAEMIA 16 0.0011
156 INFUSION SITE DISCHARGE 2 0.0011
157 ERUCTATION 22 0.0011
158 LOWER RESPIRATORY TRACT INFECTION 51 0.0011
159 LIVER FUNCTION TEST INCREASED 24 0.0011
160 JOINT ARTHROPLASTY 2 0.0011
161 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
162 ACCIDENTAL DEATH 2 0.0011
163 ADVERSE FOOD REACTION 1 0.0011
164 BLOOD CHOLESTEROL DECREASED 2 0.0011
165 HYPOGLYCAEMIC COMA 3 0.0010
166 RASH VESICULAR 5 0.0010
167 BLISTER 58 0.0010
168 MATERNAL EXPOSURE DURING PREGNANCY 91 0.0010
169 VOCAL CORD DISORDER 2 0.0010
170 INFLAMMATION 52 0.0010
171 BLOOD CULTURE POSITIVE 3 0.0010
172 DEVICE RELATED SEPSIS 2 0.0010
173 EYE INJURY 3 0.0010
174 IRON DEFICIENCY ANAEMIA 9 0.0010
175 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
176 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
177 GAIT INABILITY 32 0.0010
178 MUCOSAL INFLAMMATION 25 0.0010
179 BILE DUCT STONE 3 0.0009
180 ORTHOPNOEA 3 0.0009
181 HEPATIC ENZYME INCREASED 64 0.0009
182 HYPERPHOSPHATAEMIA 2 0.0009
183 OSTEOPOROSIS 38 0.0009
184 STOMATITIS 56 0.0009
185 HAEMORRHAGIC ANAEMIA 4 0.0009
186 HEPATIC CIRRHOSIS 17 0.0009
187 FOOT DEFORMITY 10 0.0009
188 CARDIAC FAILURE ACUTE 6 0.0009
189 LYME DISEASE 3 0.0009
190 SUSPECTED OFF LABEL USE 4 0.0009
191 ILEUS 11 0.0009
192 VASCULAR DEVICE INFECTION 4 0.0009
193 BLOOD CHOLESTEROL INCREASED 41 0.0009
194 SCIATICA 14 0.0009
195 ATRIAL FLUTTER 7 0.0009
196 INTERNATIONAL NORMALISED RATIO ABNORMAL 3 0.0009
197 METASTATIC MALIGNANT MELANOMA 2 0.0009
198 ADMINISTRATION SITE PAIN 1 0.0009
199 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
200 NECK PAIN 47 0.0008
201 CARDIOGENIC SHOCK 12 0.0008
202 WEIGHT ABNORMAL 2 0.0008
203 PANIC REACTION 6 0.0008
204 WRONG DOSE 2 0.0008
205 HAEMATOLOGICAL INFECTION 2 0.0008
206 ARTHROPATHY 45 0.0008
207 HYPERVOLAEMIA 4 0.0008
208 DEVICE INFUSION ISSUE 2 0.0008
209 HYPERNATRAEMIA 4 0.0008
210 CATHETER SITE HAEMORRHAGE 2 0.0008
211 VAGINAL DISCHARGE 8 0.0008
212 PARANASAL SINUS HYPERSECRETION 3 0.0008
213 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
214 GASTROOESOPHAGEAL REFLUX DISEASE 63 0.0008
215 PULMONARY FIBROSIS 15 0.0008
216 DEVICE RELATED INFECTION 12 0.0008
217 ELECTROLYTE IMBALANCE 9 0.0008
218 LUPUS-LIKE SYNDROME 7 0.0008
219 EAR PAIN 15 0.0008
220 FAILURE TO THRIVE 4 0.0008
221 ABDOMINAL OPERATION 1 0.0008
222 RETINAL DISORDER 2 0.0008
223 URINE OUTPUT INCREASED 2 0.0008
224 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
225 WALKING AID USER 5 0.0008
226 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
227 ACROCHORDON 1 0.0008
228 MIGRAINE 72 0.0008
229 BLOOD POTASSIUM ABNORMAL 2 0.0007
230 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
231 FULL BLOOD COUNT DECREASED 15 0.0007
232 SPINAL FUSION SURGERY 3 0.0007
233 ABDOMINAL RIGIDITY 2 0.0007
234 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
235 PRESCRIBED OVERDOSE 14 0.0007
236 TRICHORRHEXIS 2 0.0007
237 BLOOD CALCIUM DECREASED 8 0.0007
238 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12 0.0007
239 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
240 CARDIAC FAILURE CHRONIC 3 0.0007
241 DUODENAL ULCER HAEMORRHAGE 2 0.0007
242 PARAESTHESIA ORAL 10 0.0007
243 ESCHERICHIA SEPSIS 2 0.0007
244 JOINT STIFFNESS 18 0.0007
245 WRONG PATIENT RECEIVED PRODUCT 2 0.0007
246 ORAL CANDIDIASIS 9 0.0007
247 DYSPEPSIA 67 0.0007
248 MACULAR DEGENERATION 8 0.0007
249 METABOLIC ENCEPHALOPATHY 2 0.0007
250 TYPE 1 DIABETES MELLITUS 4 0.0007
251 CENTRAL VENOUS CATHETERISATION 2 0.0007
252 URINE ABNORMALITY 3 0.0007
253 AGE-RELATED MACULAR DEGENERATION 1 0.0007
254 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
255 DUODENITIS 2 0.0007
256 BRAIN DEATH 2 0.0006
257 PRE-EXISTING CONDITION IMPROVED 4 0.0006
258 MEMORY IMPAIRMENT 88 0.0006
259 SLEEP DISORDER 45 0.0006
260 PNEUMONIA VIRAL 2 0.0006
261 MALNUTRITION 7 0.0006
262 WHEEZING 37 0.0006
263 SWELLING 58 0.0006
264 GOUT 11 0.0006
265 EXPOSURE DURING PREGNANCY 38 0.0006
266 INFUSION SITE HAEMORRHAGE 2 0.0006
267 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
268 SKIN INJURY 2 0.0006
269 TONGUE ULCERATION 2 0.0006
270 AMMONIA INCREASED 3 0.0006
271 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
272 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
273 COLITIS 22 0.0006
274 DRY MOUTH 47 0.0006
275 FOETAL DEATH 3 0.0006
276 BLOOD CREATININE ABNORMAL 2 0.0006
277 ILL-DEFINED DISORDER 35 0.0006
278 AORTIC STENOSIS 2 0.0006
279 DRUG-INDUCED LIVER INJURY 18 0.0006
280 CAROTID ARTERY STENOSIS 2 0.0006
281 JOINT SWELLING 69 0.0006
282 THROMBOPHLEBITIS 2 0.0006
283 FOOD CRAVING 3 0.0006
284 POLYARTHRITIS 3 0.0006
285 SMALL INTESTINAL OBSTRUCTION 7 0.0006
286 HAEMORRHAGIC DIATHESIS 2 0.0006
287 INTENTIONAL PRODUCT USE ISSUE 49 0.0006
288 ANAL INCONTINENCE 5 0.0006
289 MONOCYTE COUNT INCREASED 2 0.0006
290 OESOPHAGITIS 6 0.0005
291 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 39 0.0005
292 CAROTID ARTERY OCCLUSION 2 0.0005
293 RHEUMATOID ARTHRITIS 62 0.0005
294 HYPERKERATOSIS 3 0.0005
295 FEBRILE NEUTROPENIA 36 0.0005
296 MUSCLE SPASMS 99 0.0005
297 RESPIRATORY DISORDER 16 0.0005
298 IMPULSIVE BEHAVIOUR 2 0.0005
299 PERIPHERAL SWELLING 82 0.0005
300 MOBILITY DECREASED 38 0.0005
301 PARANASAL SINUS DISCOMFORT 2 0.0005
302 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
303 ACUTE RESPIRATORY FAILURE 10 0.0005
304 TREATMENT FAILURE 43 0.0005
305 RALES 3 0.0005
306 FAECES HARD 2 0.0005
307 HYPERKALAEMIA 18 0.0005
308 HYPOVOLAEMIA 3 0.0005
309 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
310 RECTAL HAEMORRHAGE 22 0.0005
311 HYPOAESTHESIA 76 0.0005
312 DRUG INTOLERANCE 49 0.0005
313 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
314 OBSTRUCTION 2 0.0005
315 LOW TURNOVER OSTEOPATHY 2 0.0005
316 PREGNANCY 10 0.0005
317 ABDOMINAL DISTENSION 52 0.0005
318 GALLBLADDER OPERATION 2 0.0005
319 TOOTH ABSCESS 5 0.0005
320 DECUBITUS ULCER 4 0.0005
321 EAR INFECTION 13 0.0005
322 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
323 WEIGHT FLUCTUATION 5 0.0005
324 SWELLING OF EYELID 3 0.0005
325 TRANSFUSION 5 0.0005
326 FEELING HOT 29 0.0005
327 PURULENT DISCHARGE 2 0.0005
328 ROTATOR CUFF SYNDROME 6 0.0005
329 HAEMOGLOBIN ABNORMAL 3 0.0005
330 BLOOD POTASSIUM DECREASED 14 0.0005
331 HIATUS HERNIA 6 0.0005
332 OEDEMA 25 0.0005
333 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
334 ORTHOSTATIC HYPOTENSION 8 0.0005
335 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
336 POLYP 3 0.0005
337 PULMONARY FUNCTION TEST DECREASED 2 0.0005
338 TOOTH INFECTION 6 0.0005
339 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
340 APPETITE DISORDER 3 0.0005
341 PRESCRIBED UNDERDOSE 9 0.0005
342 WHEELCHAIR USER 2 0.0004
343 CHOLECYSTITIS CHRONIC 3 0.0004
344 BRAIN NEOPLASM MALIGNANT 2 0.0004
345 ADENOCARCINOMA 1 0.0004
346 MYOSITIS 4 0.0004
347 BRONCHIECTASIS 3 0.0004
348 PARAESTHESIA 70 0.0004
349 LABORATORY TEST ABNORMAL 13 0.0004
350 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
351 EAR DISORDER 2 0.0004
352 ABDOMINAL DISCOMFORT 73 0.0004
353 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
354 GENERAL PHYSICAL HEALTH DETERIORATION 49 0.0004
355 RED BLOOD CELL COUNT DECREASED 12 0.0004
356 SLEEP APNOEA SYNDROME 8 0.0004
357 SUBDURAL HAEMATOMA 6 0.0004
358 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
359 HYPOVOLAEMIC SHOCK 2 0.0004
360 KIDNEY TRANSPLANT REJECTION 2 0.0004
361 LOWER LIMB FRACTURE 8 0.0004
362 CARDIOMYOPATHY 6 0.0004
363 HOSPICE CARE 4 0.0004
364 BLADDER DISORDER 4 0.0004
365 AGEUSIA 10 0.0004
366 HYDRONEPHROSIS 3 0.0004
367 VEIN DISORDER 2 0.0004
368 HYPOXIA 14 0.0004
369 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
370 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
371 CORONARY ARTERIAL STENT INSERTION 2 0.0004
372 DISCOMFORT 24 0.0004
373 INSURANCE ISSUE 6 0.0004
374 BOWEL MOVEMENT IRREGULARITY 3 0.0004
375 PROCEDURAL COMPLICATION 3 0.0004
376 HYPOKALAEMIA 18 0.0004
377 CACHEXIA 2 0.0004
378 ABDOMINAL PAIN UPPER 80 0.0004
379 PERIPHERAL VASCULAR DISORDER 2 0.0004
380 INFUSION SITE PAIN 5 0.0004
381 GASTROENTERITIS VIRAL 7 0.0004
382 VARICOSE VEIN 2 0.0004
383 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
384 RESTLESS LEGS SYNDROME 7 0.0004
385 END STAGE RENAL DISEASE 7 0.0004
386 MALABSORPTION 2 0.0004
387 APLASTIC ANAEMIA 2 0.0004
388 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
389 JOINT DISLOCATION 4 0.0004
390 THERAPY NON-RESPONDER 17 0.0004
391 RESPIRATORY TRACT CONGESTION 6 0.0004
392 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
393 ADVERSE REACTION 5 0.0004
394 DECREASED APPETITE 87 0.0004
395 ALCOHOL ABUSE 1 0.0004
396 OVERWEIGHT 2 0.0004
397 PHOTOPHOBIA 7 0.0004
398 HYPOCALCAEMIA 7 0.0004
399 BLOOD POTASSIUM INCREASED 6 0.0004
400 ASTHENOPIA 2 0.0004
401 HYPERTENSION 77 0.0004
402 DEAFNESS UNILATERAL 2 0.0004
403 CHOKING SENSATION 2 0.0004
404 EMBOLISM 3 0.0004
405 STREPTOCOCCAL INFECTION 2 0.0004
406 HUNGER 5 0.0004
407 CONFUSIONAL STATE 58 0.0004
408 PLASMA CELL MYELOMA 14 0.0004
409 HEART RATE ABNORMAL 2 0.0004
410 INTESTINAL PERFORATION 4 0.0004
411 BLOOD TEST ABNORMAL 5 0.0004
412 DISABILITY 7 0.0004
413 HAEMATOCRIT DECREASED 7 0.0004
414 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
415 HYPERVENTILATION 2 0.0003
416 ADENOVIRUS INFECTION 1 0.0003
417 OEDEMA PERIPHERAL 42 0.0003
418 POST PROCEDURAL HAEMORRHAGE 4 0.0003
419 FLUID OVERLOAD 5 0.0003
420 MUSCULAR WEAKNESS 39 0.0003
421 UNDERDOSE 25 0.0003
422 BLOOD CALCIUM INCREASED 3 0.0003
423 ASTHENIA 128 0.0003
424 ATRIAL FIBRILLATION 33 0.0003
425 ENERGY INCREASED 2 0.0003
426 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
427 BACTERAEMIA 4 0.0003
428 THIRST 6 0.0003
429 COLITIS ULCERATIVE 15 0.0003
430 ODYNOPHAGIA 2 0.0003
431 HYPERLIPIDAEMIA 4 0.0003
432 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
433 PRODUCT USE IN UNAPPROVED INDICATION 82 0.0003
434 ADRENAL INSUFFICIENCY 4 0.0003
435 NASOPHARYNGITIS 60 0.0003
436 MENISCUS INJURY 2 0.0003
437 UROSEPSIS 3 0.0003
438 PROCEDURAL PAIN 9 0.0003
439 PRODUCT DISTRIBUTION ISSUE 3 0.0003
440 GENERALISED OEDEMA 4 0.0003
441 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
442 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
443 OLIGURIA 2 0.0003
444 HEPATIC ENCEPHALOPATHY 3 0.0003
445 INFUSION SITE EXTRAVASATION 2 0.0003
446 FLANK PAIN 3 0.0003
447 LACERATION 3 0.0003
448 SQUAMOUS CELL CARCINOMA 3 0.0003
449 FLUID RETENTION 16 0.0003
450 PREMATURE DELIVERY 5 0.0003
451 SEPSIS 35 0.0003
452 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
453 ORAL PAIN 7 0.0003
454 ENTERITIS 2 0.0003
455 SINUSITIS 32 0.0003
456 CONTUSION 30 0.0003
457 CARDIAC FLUTTER 2 0.0003
458 ANAEMIA 59 0.0003
459 WEIGHT INCREASED 69 0.0003
460 HAEMATOCHEZIA 17 0.0003
461 DYSPHONIA 18 0.0003
462 EPISTAXIS 23 0.0003
463 TENDON DISORDER 2 0.0003
464 ASCITES 9 0.0003
465 COELIAC DISEASE 3 0.0003
466 BODY TEMPERATURE DECREASED 3 0.0003
467 SOMNAMBULISM 2 0.0003
468 HYPOGAMMAGLOBULINAEMIA 2 0.0003
469 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
470 PHOTOSENSITIVITY REACTION 5 0.0003
471 HYPONATRAEMIA 17 0.0003
472 ACUTE KIDNEY INJURY 46 0.0003
473 DEPRESSION 68 0.0003
474 INJURY 21 0.0003
475 METASTASES TO LYMPH NODES 2 0.0003
476 SINUS CONGESTION 4 0.0003
477 PRODUCT QUALITY ISSUE 40 0.0003
478 GINGIVAL BLEEDING 4 0.0003
479 EUPHORIC MOOD 3 0.0003
480 HAEMOGLOBIN DECREASED 30 0.0003
481 SCAR 5 0.0003
482 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
483 PULMONARY OEDEMA 13 0.0003
484 ALOPECIA 57 0.0003
485 JOINT EFFUSION 2 0.0003
486 POOR VENOUS ACCESS 3 0.0003
487 PULMONARY HYPERTENSION 6 0.0003
488 HYPERTRANSAMINASAEMIA 2 0.0003
489 EXTRASYSTOLES 2 0.0003
490 DEHYDRATION 38 0.0003
491 BRONCHITIS 21 0.0003
492 DUODENAL ULCER 2 0.0003
493 RENAL PAIN 3 0.0003
494 CYSTITIS 9 0.0003
495 DIALYSIS 4 0.0003
496 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
497 HIP FRACTURE 9 0.0003
498 GASTROINTESTINAL DISORDER 25 0.0003
499 RENAL DISORDER 13 0.0003
500 ARTHRALGIA 116 0.0003
501 LACTIC ACIDOSIS 9 0.0003
502 THROMBOCYTOPENIA 31 0.0003
503 MYELODYSPLASTIC SYNDROME 4 0.0003
504 HYPOPHAGIA 7 0.0003
505 PNEUMONIA 88 0.0003
506 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
507 HYPOPHOSPHATAEMIA 2 0.0003
508 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
509 HAEMATOMA 7 0.0003
510 VENTRICULAR FIBRILLATION 3 0.0003
511 OROPHARYNGEAL PAIN 25 0.0003
512 NERVE INJURY 3 0.0003
513 URINARY TRACT INFECTION 46 0.0003
514 PULMONARY MASS 4 0.0003
515 IMMUNODEFICIENCY 4 0.0003
516 SKIN INFECTION 3 0.0003
517 GENERAL SYMPTOM 2 0.0003
518 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
519 CARDIAC ARREST 22 0.0003
520 INTESTINAL OBSTRUCTION 10 0.0003
521 FLATULENCE 15 0.0003
522 TENDON PAIN 2 0.0003
523 HYPERSENSITIVITY 49 0.0003
524 FOOT FRACTURE 5 0.0003
525 PYREXIA 91 0.0003
526 ROAD TRAFFIC ACCIDENT 11 0.0003
527 PLEURAL EFFUSION 16 0.0003
528 HIP ARTHROPLASTY 4 0.0003
529 LIMB INJURY 7 0.0003
530 BASAL CELL CARCINOMA 4 0.0003
531 HAEMORRHOIDS 5 0.0003
532 PRODUCT USE ISSUE 48 0.0003
533 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
534 COVID-19 PNEUMONIA 3 0.0003
535 PLATELET COUNT DECREASED 27 0.0003
536 DIZZINESS 126 0.0003
537 DIVERTICULITIS 7 0.0003
538 SINUS DISORDER 5 0.0003
539 BLOOD ALBUMIN DECREASED 2 0.0003
540 PRODUCT PRESCRIBING ERROR 6 0.0003
541 RENAL CYST 2 0.0003
542 TRICUSPID VALVE INCOMPETENCE 2 0.0003
543 GAIT DISTURBANCE 48 0.0003
544 VISUAL IMPAIRMENT 31 0.0002
545 CHRONIC KIDNEY DISEASE 19 0.0002
546 LIVER DISORDER 11 0.0002
547 DIARRHOEA 160 0.0002
548 INJECTION SITE REACTION 17 0.0002
549 NEURALGIA 6 0.0002
550 BACK DISORDER 4 0.0002
551 BODY TEMPERATURE INCREASED 5 0.0002
552 HICCUPS 2 0.0002
553 STAPHYLOCOCCAL INFECTION 8 0.0002
554 COAGULOPATHY 4 0.0002
555 URTICARIA 40 0.0002
556 KNEE ARTHROPLASTY 5 0.0002
557 INFUSION SITE ERYTHEMA 2 0.0002
558 MUSCLE ATROPHY 3 0.0002
559 URINARY INCONTINENCE 7 0.0002
560 INTRAOCULAR PRESSURE INCREASED 3 0.0002
561 HYPOTENSION 47 0.0002
562 JOINT INJURY 5 0.0002
563 VOMITING 110 0.0002
564 VITAMIN D DECREASED 2 0.0002
565 MEDICATION ERROR 13 0.0002
566 ALCOHOLISM 1 0.0002
567 PAIN 143 0.0002
568 OCULAR HYPERAEMIA 11 0.0002
569 CARDIAC MURMUR 2 0.0002
570 DELIRIUM 8 0.0002
571 PLATELET COUNT INCREASED 3 0.0002
572 ADVERSE EVENT 21 0.0002
573 PANCREATITIS 12 0.0002
574 LUNG INFILTRATION 2 0.0002
575 ABDOMINAL ABSCESS 1 0.0002
576 PURPURA 2 0.0002
577 RESPIRATORY RATE INCREASED 2 0.0002
578 HAIR TEXTURE ABNORMAL 3 0.0002
579 PANCREATITIS ACUTE 5 0.0002
580 LEUKOCYTOSIS 4 0.0002
581 NEUROPATHY PERIPHERAL 21 0.0002
582 ABDOMINAL HERNIA 1 0.0002
583 CORONARY ARTERY OCCLUSION 3 0.0002
584 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
585 CELLULITIS 11 0.0002
586 INCREASED TENDENCY TO BRUISE 2 0.0002
587 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
588 RHABDOMYOLYSIS 9 0.0002
589 RASH 94 0.0002
590 AGRANULOCYTOSIS 4 0.0002
591 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
592 NEPHROPATHY 2 0.0002
593 INFECTION 31 0.0002
594 TACHYCARDIA 19 0.0002
595 ARTERIOSCLEROSIS 2 0.0002
596 DYSPNOEA EXERTIONAL 8 0.0002
597 LEUKAEMIA 2 0.0002
598 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
599 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
600 SPINAL DISORDER 2 0.0002
601 MUSCULOSKELETAL DISORDER 4 0.0002
602 URINARY RETENTION 7 0.0002
603 EYE INFLAMMATION 2 0.0002
604 INCREASED APPETITE 4 0.0002
605 HERPES ZOSTER 12 0.0002
606 LETHARGY 12 0.0002
607 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
608 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
609 CONSTIPATION 45 0.0002
610 GASTROENTERITIS 3 0.0002
611 VITAMIN D DEFICIENCY 2 0.0002
612 PHARYNGEAL SWELLING 2 0.0002
613 FALL 68 0.0002
614 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
615 ENCEPHALOPATHY 5 0.0002
616 HEPATOMEGALY 2 0.0002
617 VITREOUS FLOATERS 2 0.0002
618 KNEE OPERATION 2 0.0002
619 LIGAMENT SPRAIN 2 0.0002
620 FATIGUE 157 0.0002
621 INABILITY TO AFFORD MEDICATION 2 0.0002
622 NEOPLASM PROGRESSION 7 0.0002
623 BLOOD PRESSURE ABNORMAL 4 0.0002
624 WEIGHT DECREASED 56 0.0002
625 ADVERSE DRUG REACTION 18 0.0002
626 AMNESIA 13 0.0002
627 DYSPNOEA 113 0.0002
628 HEART RATE DECREASED 7 0.0002
629 CARDIAC FAILURE 16 0.0002
630 NEUTROPENIA 27 0.0002
631 PRODUCT ADMINISTRATION ERROR 4 0.0002
632 BLOOD COUNT ABNORMAL 3 0.0002
633 LYMPHADENOPATHY 7 0.0002
634 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
635 DRUG LEVEL DECREASED 2 0.0002
636 SLUGGISHNESS 2 0.0002
637 OXYGEN SATURATION DECREASED 11 0.0002
638 HOSPITALISATION 30 0.0002
639 INITIAL INSOMNIA 2 0.0002
640 EAR DISCOMFORT 2 0.0002
641 THYROID DISORDER 3 0.0002
642 ILLNESS 20 0.0002
643 TENDONITIS 3 0.0002
644 ABDOMINAL PAIN 45 0.0002
645 HYPERBILIRUBINAEMIA 2 0.0002
646 EJECTION FRACTION DECREASED 3 0.0002
647 RESPIRATORY FAILURE 14 0.0002
648 BRAIN FOG 3 0.0002
649 PRODUCT USE COMPLAINT 3 0.0002
650 GASTRITIS 5 0.0002
651 BLOOD PRESSURE INCREASED 29 0.0002
652 SCRATCH 2 0.0002
653 PULMONARY EMBOLISM 18 0.0002
654 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
655 FULL BLOOD COUNT ABNORMAL 2 0.0002
656 BRADYCARDIA 10 0.0002
657 HEADACHE 118 0.0002
658 METABOLIC ACIDOSIS 6 0.0002
659 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
660 SENSORY DISTURBANCE 3 0.0002
661 CARDIAC FAILURE CONGESTIVE 15 0.0002
662 ANXIETY 53 0.0002
663 HYPOACUSIS 8 0.0002
664 MALIGNANT NEOPLASM PROGRESSION 19 0.0002
665 MUSCLE TIGHTNESS 3 0.0002
666 MALAISE 81 0.0002
667 RASH PRURITIC 10 0.0002
668 CONDITION AGGRAVATED 56 0.0002
669 BIPOLAR DISORDER 2 0.0002
670 PAIN IN EXTREMITY 54 0.0002
671 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
672 ASPIRATION 2 0.0002
673 BLOOD GLUCOSE FLUCTUATION 2 0.0002
674 SKIN LESION 5 0.0002
675 NAUSEA 144 0.0002
676 RESPIRATORY DISTRESS 5 0.0002
677 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
678 HAEMOPTYSIS 5 0.0002
679 BLOOD UREA INCREASED 3 0.0002
680 RENAL IMPAIRMENT 15 0.0002
681 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
682 EYE INFECTION 2 0.0002
683 STATUS EPILEPTICUS 2 0.0002
684 INSOMNIA 47 0.0002
685 CIRCULATORY COLLAPSE 3 0.0002
686 PRODUCT AVAILABILITY ISSUE 4 0.0002
687 SCAB 2 0.0002
688 MICTURITION URGENCY 2 0.0002
689 HYPERSOMNIA 5 0.0002
690 MUSCULOSKELETAL DISCOMFORT 3 0.0002
691 GASTRIC HAEMORRHAGE 2 0.0002
692 MUSCLE TWITCHING 4 0.0002
693 OFF LABEL USE 151 0.0002
694 MADAROSIS 2 0.0002
695 NEUTROPHIL COUNT DECREASED 7 0.0002
696 VASCULITIS 2 0.0002
697 CARDIAC DISORDER 16 0.0002
698 SPLENOMEGALY 2 0.0002
699 CHILLS 20 0.0002
700 SEXUAL DYSFUNCTION 2 0.0002
701 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
702 SWELLING FACE 11 0.0002
703 TREMOR 28 0.0002
704 PRODUCTIVE COUGH 8 0.0002
705 RASH ERYTHEMATOUS 8 0.0002
706 PRODUCT DOSE OMISSION ISSUE 49 0.0002
707 TOOTHACHE 3 0.0002
708 APHASIA 5 0.0002
709 LACRIMATION INCREASED 5 0.0002
710 COVID-19 29 0.0002
711 HYPERGLYCAEMIA 6 0.0002
712 MUSCLE SPASTICITY 2 0.0002
713 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
714 CARDIOMEGALY 2 0.0002
715 BLOOD GLUCOSE ABNORMAL 3 0.0002
716 SPINAL OPERATION 2 0.0002
717 CONJUNCTIVITIS 3 0.0002
718 EYE SWELLING 6 0.0002
719 HEPATIC STEATOSIS 3 0.0002
720 SEPTIC SHOCK 7 0.0002
721 DRY EYE 8 0.0002
722 PNEUMONIA ASPIRATION 4 0.0002
723 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
724 FOETAL EXPOSURE DURING PREGNANCY 13 0.0002
725 SECRETION DISCHARGE 2 0.0002
726 POISONING 2 0.0002
727 INJECTION SITE IRRITATION 2 0.0002
728 COUGH 44 0.0002
729 HEPATITIS 4 0.0002
730 POST PROCEDURAL COMPLICATION 3 0.0002
731 SKIN ULCER 4 0.0002
732 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
733 RESPIRATORY TRACT INFECTION 4 0.0002
734 NODULE 2 0.0002
735 KIDNEY INFECTION 3 0.0002
736 NEPHROLITHIASIS 7 0.0002
737 INFLUENZA 17 0.0002
738 SKIN DISCOLOURATION 7 0.0002
739 RENAL FAILURE 20 0.0002
740 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
741 UPPER LIMB FRACTURE 3 0.0002
742 LIP SWELLING 5 0.0001
743 FUNGAL INFECTION 5 0.0001
744 MALIGNANT MELANOMA 2 0.0001
745 QUALITY OF LIFE DECREASED 2 0.0001
746 EYE PRURITUS 5 0.0001
747 MUSCULOSKELETAL STIFFNESS 13 0.0001
748 OVERDOSE 32 0.0001
749 VERTIGO 9 0.0001
750 TACHYPNOEA 2 0.0001
751 PALLOR 4 0.0001
752 PNEUMONITIS 4 0.0001
753 IMPAIRED GASTRIC EMPTYING 2 0.0001
754 ABNORMAL LOSS OF WEIGHT 1 0.0001
755 BACK PAIN 34 0.0001
756 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
757 GASTRIC DISORDER 5 0.0001
758 MENTAL STATUS CHANGES 4 0.0001
759 FEELING COLD 4 0.0001
760 DISEASE PROGRESSION 17 0.0001
761 DERMATITIS 3 0.0001
762 PANCYTOPENIA 8 0.0001
763 MASS 2 0.0001
764 RASH MACULAR 5 0.0001
765 CARPAL TUNNEL SYNDROME 2 0.0001
766 MOUTH ULCERATION 3 0.0001
767 DEVICE OCCLUSION 2 0.0001
768 BLINDNESS UNILATERAL 2 0.0001
769 SINUS TACHYCARDIA 2 0.0001
770 RETCHING 3 0.0001
771 IMPAIRED WORK ABILITY 3 0.0001
772 POOR QUALITY SLEEP 3 0.0001
773 SKIN CANCER 3 0.0001
774 BALANCE DISORDER 12 0.0001
775 DEEP VEIN THROMBOSIS 9 0.0001
776 FAECES DISCOLOURED 3 0.0001
777 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
778 BLOOD CREATININE INCREASED 9 0.0001
779 HYPOKINESIA 2 0.0001
780 BONE PAIN 8 0.0001
781 MELAENA 3 0.0001
782 BLOOD PRESSURE DECREASED 9 0.0001
783 MYALGIA 23 0.0001
784 CHEST PAIN 25 0.0001
785 SKIN HAEMORRHAGE 2 0.0001
786 TOOTH DISORDER 3 0.0001
787 RENAL INJURY 4 0.0001
788 DYSGEUSIA 10 0.0001
789 CATARACT 8 0.0001
790 NERVOUSNESS 7 0.0001
791 HAEMORRHAGE INTRACRANIAL 2 0.0001
792 SPEECH DISORDER 7 0.0001
793 ASTHMA 15 0.0001
794 HYPOAESTHESIA ORAL 2 0.0001
795 CORONARY ARTERY DISEASE 4 0.0001
796 ECONOMIC PROBLEM 2 0.0001
797 OSTEOPENIA 2 0.0001
798 ACIDOSIS 1 0.0001
799 PERICARDIAL EFFUSION 3 0.0001
800 MUSCULOSKELETAL CHEST PAIN 2 0.0001
801 FEMUR FRACTURE 4 0.0001
802 SOMNOLENCE 26 0.0001
803 AFFECTIVE DISORDER 1 0.0001
804 ARTHRITIS 10 0.0001
805 ERYTHEMA 26 0.0001
806 DYSPHAGIA 12 0.0001
807 HEAD INJURY 4 0.0001
808 DISEASE RECURRENCE 6 0.0001
809 ULCER 2 0.0001
810 BLOOD GLUCOSE DECREASED 6 0.0001
811 LOSS OF CONSCIOUSNESS 16 0.0001
812 EYE PAIN 7 0.0001
813 HYPOGLYCAEMIA 6 0.0001
814 DYSKINESIA 5 0.0001
815 ABNORMAL FAECES 1 0.0001
816 EYE IRRITATION 7 0.0001
817 VENTRICULAR TACHYCARDIA 2 0.0001
818 ACUTE CORONARY SYNDROME 1 0.0001
819 CYTOMEGALOVIRUS INFECTION 2 0.0001
820 LEUKOPENIA 6 0.0001
821 PALPITATIONS 14 0.0001
822 FACE OEDEMA 2 0.0001
823 CANDIDA INFECTION 2 0.0001
824 GASTRIC CANCER 3 0.0001
825 HAEMATEMESIS 3 0.0001
826 HEMIPARESIS 2 0.0001
827 RENAL FAILURE ACUTE 5 0.0001
828 CHEST DISCOMFORT 12 0.0001
829 HAEMATURIA 4 0.0001
830 BLOOD GLUCOSE INCREASED 22 0.0001
831 UNRESPONSIVE TO STIMULI 3 0.0001
832 EXPOSURE VIA SKIN CONTACT 3 0.0001
833 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
834 DIPLOPIA 3 0.0001
835 DEAFNESS 3 0.0001
836 SEDATION 3 0.0001
837 PRURITUS 44 0.0001
838 SYRINGE ISSUE 2 0.0001
839 INTENTIONAL PRODUCT MISUSE 10 0.0001
840 LYMPHOCYTE COUNT DECREASED 2 0.0001
841 HEAD DISCOMFORT 2 0.0001
842 FEELING ABNORMAL 27 0.0001
843 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
844 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
845 BLOOD BILIRUBIN INCREASED 3 0.0001
846 OSTEOMYELITIS 2 0.0001
847 BONE DISORDER 2 0.0001
848 TINNITUS 5 0.0001
849 THINKING ABNORMAL 2 0.0001
850 PRODUCT DOSE OMISSION 7 0.0001
851 COGNITIVE DISORDER 5 0.0001
852 SKIN EXFOLIATION 9 0.0001
853 HOT FLUSH 8 0.0001
854 BLOOD SODIUM DECREASED 2 0.0001
855 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
856 FRACTURE 2 0.0001
857 BLOOD URINE PRESENT 2 0.0001
858 PROTEINURIA 2 0.0001
859 DIABETES MELLITUS 8 0.0001
860 HERNIA 2 0.0001
861 INTERSTITIAL LUNG DISEASE 5 0.0001
862 DYSSTASIA 3 0.0001
863 CHOKING 2 0.0001
864 SURGERY 6 0.0001
865 NASAL CONGESTION 6 0.0001
866 ACUTE MYOCARDIAL INFARCTION 3 0.0001
867 DISORIENTATION 4 0.0001
868 BURNING SENSATION 7 0.0001
869 SPINAL FRACTURE 2 0.0001
870 CYTOKINE RELEASE SYNDROME 2 0.0001
871 THROMBOSIS 8 0.0001
872 THERAPEUTIC RESPONSE DECREASED 6 0.0001
873 FEEDING DISORDER 2 0.0001
874 THERAPY INTERRUPTED 7 0.0001
875 DRUG ADMINISTRATION ERROR 3 0.0001
876 DEATH 84 0.0001
877 INFLUENZA LIKE ILLNESS 8 0.0001
878 LIMB DISCOMFORT 3 0.0001
879 SWOLLEN TONGUE 3 0.0001
880 POLLAKIURIA 4 0.0001
881 HALLUCINATION, VISUAL 2 0.0001
882 DEPRESSED MOOD 5 0.0001
883 HYPOTHYROIDISM 3 0.0001
884 RHINORRHOEA 6 0.0001
885 UNEVALUABLE EVENT 7 0.0001
886 PRODUCT PRESCRIBING ISSUE 2 0.0001
887 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
888 CHOLELITHIASIS 3 0.0001
889 HEART RATE INCREASED 9 0.0001
890 VISUAL ACUITY REDUCED 3 0.0001
891 DRUG INEFFECTIVE 119 0.0001
892 SYNCOPE 9 0.0001
893 TRANSAMINASES INCREASED 2 0.0001
894 SKIN DISORDER 3 0.0001
895 RASH MACULO-PAPULAR 2 0.0001
896 SNEEZING 2 0.0001
897 SHOCK 2 0.0001
898 SEIZURE 10 0.0001
899 HAEMORRHAGE 9 0.0001
900 DEVICE MALFUNCTION 6 0.0001
901 ARRHYTHMIA 4 0.0001
902 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
903 IRRITABILITY 5 0.0001
904 NO ADVERSE EVENT 15 0.0001
905 CRYING 3 0.0001
906 PANIC ATTACK 3 0.0001
907 PRESYNCOPE 2 0.0001
908 ACCIDENTAL OVERDOSE 3 0.0001
909 RESTLESSNESS 3 0.0001
910 INJECTION SITE URTICARIA 2 0.0001
911 HEPATIC FUNCTION ABNORMAL 3 0.0001
912 VISION BLURRED 11 0.0001
913 THERAPY CESSATION 4 0.0001
914 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
915 ANHEDONIA 2 0.0001
916 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
917 DRY SKIN 10 0.0001
918 NEOPLASM MALIGNANT 5 0.0001
919 INJECTION SITE PRURITUS 5 0.0001
920 ACUTE HEPATIC FAILURE 1 0.0001
921 TREATMENT NONCOMPLIANCE 4 0.0001
922 RESPIRATORY ARREST 2 0.0001
923 ABNORMAL DREAMS 2 0.0001
924 ANAPHYLACTIC REACTION 4 0.0001
925 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
926 DEMENTIA 2 0.0001
927 CEREBROVASCULAR ACCIDENT 12 0.0001
928 INTENTIONAL DOSE OMISSION 2 0.0001
929 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
930 PANCREATIC CARCINOMA 2 0.0001
931 DEVICE DISLOCATION 3 0.0001
932 LIVER FUNCTION TEST ABNORMAL 2 0.0001
933 NEEDLE ISSUE 2 0.0001
934 PSYCHOTIC DISORDER 2 0.0001
935 PREMATURE BABY 2 0.0001
936 HEPATIC FAILURE 2 0.0001
937 SUICIDAL IDEATION 6 0.0001
938 INJECTION SITE SWELLING 5 0.0001
939 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
940 NERVOUS SYSTEM DISORDER 2 0.0001
941 BONE DENSITY DECREASED 2 0.0001
942 MYOCARDIAL INFARCTION 11 0.0001
943 MOOD SWINGS 2 0.0001
944 MULTIPLE SCLEROSIS 3 0.0001
945 PROSTATE CANCER 5 0.0001
946 HYPERHIDROSIS 8 0.0001
947 PSORIASIS 8 0.0001
948 EYE DISORDER 2 0.0001
949 AGGRESSION 3 0.0001
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
951 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
952 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
953 EMOTIONAL DISTRESS 7 0.0001
954 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
955 CEREBRAL HAEMORRHAGE 2 0.0001
956 DISTURBANCE IN ATTENTION 3 0.0001
957 DRUG EFFECT INCOMPLETE 2 0.0001
958 DRUG DOSE OMISSION 9 0.0001
959 DYSURIA 2 0.0001
960 DYSARTHRIA 2 0.0001
961 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
962 DRUG INTERACTION 8 0.0001
963 ABORTION SPONTANEOUS 2 0.0000
964 LUNG NEOPLASM MALIGNANT 2 0.0000
965 INJECTION SITE ERYTHEMA 6 0.0000
966 CARDIO-RESPIRATORY ARREST 2 0.0000
967 WITHDRAWAL SYNDROME 2 0.0000
968 TOXICITY TO VARIOUS AGENTS 8 0.0000
969 INJECTION SITE PAIN 14 0.0000
970 SKIN IRRITATION 2 0.0000
971 ABASIA 1 0.0000
972 HALLUCINATION 3 0.0000
973 ACNE 3 0.0000
974 ABDOMINAL PAIN LOWER 1 0.0000
975 FLUSHING 4 0.0000
976 INJECTION SITE BRUISING 3 0.0000
977 INJECTION SITE HAEMORRHAGE 3 0.0000
978 DRUG EFFECT DECREASED 2 0.0000
979 INCORRECT DOSE ADMINISTERED 8 0.0000
980 PRODUCT SUBSTITUTION ISSUE 2 0.0000
981 DRUG WITHDRAWAL SYNDROME 3 0.0000
982 BLADDER CANCER 2 0.0000
983 DEVICE ISSUE 3 0.0000
984 SUICIDE ATTEMPT 2 0.0000
985 BREAST CANCER 3 0.0000
986 SKIN BURNING SENSATION 2 0.0000
987 AGITATION 2 0.0000
988 DRUG ABUSE 2 0.0000
989 DRUG DEPENDENCE 3 0.0000